http://rdf.ncbi.nlm.nih.gov/pubchem/patent/DE-2264764-A1
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_838cee78914619aafc3c752655e1fcc4 |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12P7-48 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12P7-48 |
| filingDate | 1972-03-17-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_a19141e76eaf11f542b5452a354c4fe3 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_06277413e7631b5064ec991e23751f54 |
| publicationDate | 1975-03-20-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | DE-2264764-A1 |
| titleOfInvention | PROCESS FOR THE PRODUCTION OF YEAST MUTANTS WITH HIGH CITRIC ACID FORMATION |
| abstract | Yeast mutants with increased citric acid-producing activity are obtd. by treating known citric acid-producing yeasts with mutation-inducing media, inoculating the treated yeast cells into a nutrient medium and culturing in the presence of increasing concentrations an aconitase inhibitor or a citric acid antimetabolite or their precursors and the enriched yeast mutant is then isolated. A final concn. of aconitase-inhibitor, etc. of 1 mol/l. is used. The critic acid antimetabolite is pref. a monofluoroacetate. The yeast strain is pref. Candida oleophila or Candida lipolytica. |
| isCitedBy | http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-0450491-A2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-0450491-A3 |
| priorityDate | 1972-03-17-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 116.